ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51653
-0.06%
Bitcoin
69,280.00
-0.06%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Sorrento Therapeutics Inc (CE) (SRNEQ)

  7. Sorrento Therapeutics Inc (CE) (SRNEQ) News

SRNEQ

Sorrento Therapeutics (CE) (SRNEQ)

Sorrento Therapeutics Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SRNEQ
DateTimeSourceHeadlineSymbolCompany
08/11/202308:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
06/10/202308:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
06/10/202308:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
06/10/202308:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
27/09/202306:54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
27/09/202306:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
26/09/202306:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
22/08/202301:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
11/08/202306:14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
19/07/202307:23Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:SRNEQSorrento Therapeutics Inc (CE)
08/07/202311:49Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
22/06/202307:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
21/06/202307:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
15/06/202323:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
19/05/202320:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
16/05/202305:18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
16/05/202302:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
13/05/202307:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
09/05/202320:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
03/05/202320:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
21/04/202307:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
21/04/202302:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
12/04/202322:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:SRNEQSorrento Therapeutics Inc (CE)
11/04/202307:23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
11/04/202305:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
31/03/202321:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
21/03/202310:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/03/202321:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
11/03/202303:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
09/03/202306:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:SRNEQ

Your Recent History

TSX
VMH.U
VM Hotel Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved